$XXII
22nd Century Group, Inc. Stock $xxii

$xxii Overview Financials Valuation SEC Filings Company Website

2013 Q2 Form 10-Q Financial Statement

#000114420413042850 Filed on August 05, 2013

Income Statement

Concept	2013 Q2	2012 Q2
Revenue	$0.00	$0.00
YoY Change		-100.0%
Cost Of Revenue	$0.00	$0.00
YoY Change		-100.0%
Gross Profit	$0.00	$0.00
YoY Change		-100.0%
Gross Profit Margin
Selling, General & Admin	$1.401M	$1.083M
YoY Change	29.32%	64.09%
% of Gross Profit
Research & Development	$165.1K	$241.3K
YoY Change	-31.57%	-58.4%
% of Gross Profit
Depreciation & Amortization	$60.00K	$50.00K
YoY Change	20.0%	0.0%
% of Gross Profit
Operating Expenses	$1.566M	$1.324M
YoY Change	18.23%	2.65%
Operating Profit	-$1.623M	-$1.374M
YoY Change	18.07%	26.07%
Interest Expense	$1.180M	$1.520M
YoY Change	-22.37%	-7700.0%
% of Operating Profit
Other Income/Expense, Net	$1.177M	$1.516M
YoY Change	-22.38%
Pretax Income	-$450.0K	$140.0K
YoY Change	-421.43%	-112.73%
Income Tax	$0.00	$0.00
% Of Pretax Income		0.0%
Net Earnings	-$446.0K	$141.8K
YoY Change	-414.57%	-112.89%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.01	$0.00
Diluted Earnings Per Share	-$0.01	$0.00
COMMON SHARES
Basic Shares Outstanding	39.79M shares	29.26M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2013 Q2	2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$450.0K	$0.00
YoY Change		-100.0%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets	$30.00K	$50.00K
YoY Change	-40.0%	-66.67%
Inventory	$1.257M	$1.170M
Prepaid Expenses	$32.85K
Receivables	$40.00K	$20.00K
Other Receivables	$10.00K	$10.00K
Total Short-Term Assets	$1.789M	$1.260M
YoY Change	41.95%	-4.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$27.80K	$10.00K
YoY Change	178.04%
Goodwill
YoY Change
Intangibles	$1.345M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00	$60.00K
YoY Change	-100.0%
Total Long-Term Assets	$1.373M	$1.430M
YoY Change	-3.99%	-0.69%
TOTAL ASSETS
Total Short-Term Assets	$1.789M	$1.260M
Total Long-Term Assets	$1.373M	$1.430M
Total Assets	$3.161M	$2.690M
YoY Change	17.53%	-2.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$422.5K	$1.120M
YoY Change	-62.27%	-7.44%
Accrued Expenses	$329.9K	$440.0K
YoY Change	-25.03%	120.0%
Deferred Revenue
YoY Change
Short-Term Debt	$370.0K	$1.420M
YoY Change	-73.94%	735.29%
Long-Term Debt Due	$1.050M	$480.0K
YoY Change	118.75%	300.0%
Total Short-Term Liabilities	$2.279M	$3.460M
YoY Change	-34.14%	93.3%
LONG-TERM LIABILITIES
Long-Term Debt	$180.0K	$140.0K
YoY Change	28.57%	-77.78%
Other Long-Term Liabilities	$7.920M	$1.100M
YoY Change	620.0%	-64.05%
Total Long-Term Liabilities	$8.100M	$1.240M
YoY Change	553.23%	-66.4%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.279M	$3.460M
Total Long-Term Liabilities	$8.100M	$1.240M
Total Liabilities	$10.37M	$4.690M
YoY Change	121.14%	-14.42%
SHAREHOLDERS EQUITY
Retained Earnings	-$16.74M
YoY Change
Common Stock	$444.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$7.210M	-$2.000M
YoY Change
Total Liabilities & Shareholders Equity	$3.161M	$2.690M
YoY Change	17.53%	-2.54%

Cashflow Statement

Concept	2013 Q2	2012 Q2
OPERATING ACTIVITIES
Net Income	-$446.0K	$141.8K
YoY Change	-414.57%	-112.89%
Depreciation, Depletion And Amortization	$60.00K	$50.00K
YoY Change	20.0%	0.0%
Cash From Operating Activities	-$370.0K	-$750.0K
YoY Change	-50.67%	17.19%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change
Cash From Investing Activities	$0.00	$0.00
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	550.0K	760.0K
YoY Change	-27.63%	-733.33%
NET CHANGE
Cash From Operating Activities	-370.0K	-750.0K
Cash From Investing Activities	0.000	0.000
Cash From Financing Activities	550.0K	760.0K
Net Change In Cash	180.0K	10.00K
YoY Change	1700.0%	-101.25%
FREE CASH FLOW
Cash From Operating Activities	-$370.0K	-$750.0K
Capital Expenditures	$0.00	$0.00
Free Cash Flow	-$370.0K	-$750.0K
YoY Change	-50.67%	22.95%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q4	us-gaap	Assets Current AssetsCurrent	1281305	USD
	dei	Trading Symbol TradingSymbol	XXII
CY2013Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	46140518	shares
	dei	Entity Registrant Name EntityRegistrantName	22nd Century Group, Inc.
	dei	Entity Central Index Key EntityCentralIndexKey	0001347858
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2013Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2013Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2013Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2013Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	44378331	shares
CY2013Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	44378331	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34286979	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34286979	shares
CY2013Q2	us-gaap	Cash Cash	451730	USD
CY2012Q4	us-gaap	Cash Cash	188	USD
CY2013Q2	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	39469	USD
CY2012Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	36969	USD
CY2013Q2	us-gaap	Due From Officers Or Stockholders Current DueFromOfficersOrStockholdersCurrent	7471	USD
CY2012Q4	us-gaap	Due From Officers Or Stockholders Current DueFromOfficersOrStockholdersCurrent	3578	USD
CY2013Q2	us-gaap	Inventory Net InventoryNet	1257059	USD
CY2012Q4	us-gaap	Inventory Net InventoryNet	1230526	USD
CY2013Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	32846	USD
CY2012Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	10044	USD
CY2013Q2	us-gaap	Assets Current AssetsCurrent	1788575	USD
CY2013Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1345080	USD
CY2012Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1353304	USD
CY2013Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27804	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6030	USD
CY2013Q2	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	0	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	355835	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	912480	USD
	xxii	Number Of Warrants Exercised NumberOfWarrantsExercised	-982300	shares
CY2012Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	4232	USD
CY2013Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	1372884	USD
CY2012Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1363566	USD
CY2013Q2	us-gaap	Assets Assets	3161459	USD
CY2012Q4	us-gaap	Assets Assets	2644871	USD
CY2013Q2	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	174925	USD
CY2012Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	174925	USD
CY2013Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	422548	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1410650	USD
CY2013Q2	xxii	Interest Payable Related Parties Current InterestPayableRelatedPartiesCurrent	9739	USD
CY2012Q4	xxii	Interest Payable Related Parties Current InterestPayableRelatedPartiesCurrent	3567	USD
CY2013Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	329854	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	503002	USD
CY2013Q2	us-gaap	Dividends Payable Current DividendsPayableCurrent	93361	USD
CY2012Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	0	USD
CY2013Q2	us-gaap	Notes Payable Current NotesPayableCurrent	1050013	USD
CY2012Q4	us-gaap	Notes Payable Current NotesPayableCurrent	617000	USD
CY2013Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	198367	USD
CY2012Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1893804	USD
CY2013Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2278807	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4602948	USD
CY2013Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	175000	USD
CY2012Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	USD
CY2013Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	7917730	USD
CY2012Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	4173140	USD
CY2013Q2	us-gaap	Liabilities Liabilities	10371537	USD
CY2012Q4	us-gaap	Liabilities Liabilities	8776088	USD
CY2013Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q2	us-gaap	Common Stock Value CommonStockValue	444	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	344	USD
CY2013Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	9525214	USD
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	7645017	USD
CY2013Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16735736	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13776578	USD
CY2013Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7210078	USD
CY2012Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-6131217	USD
CY2013Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3161459	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2644871	USD
CY2013Q2	xxii	Liabilities Excluding Warrant Liability LiabilitiesExcludingWarrantLiability	2453807	USD
CY2012Q4	xxii	Liabilities Excluding Warrant Liability LiabilitiesExcludingWarrantLiability	4602948	USD
CY2013Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
	us-gaap	Sales Revenue Net SalesRevenueNet	0	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	0	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	328998	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2548647	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1361922	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	0	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	34682	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	109600	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	95916	USD
	us-gaap	Costs And Expenses CostsAndExpenses	3014082	USD
	us-gaap	Costs And Expenses CostsAndExpenses	1821518	USD
	xxii	Non Cash Interest On Convertible Debt NonCashInterestOnConvertibleDebt	31350	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1821518	USD
	xxii	Derivative Gains Losses Net DerivativeGainsLossesNet	242327	USD
	xxii	Derivative Gains Losses Net DerivativeGainsLossesNet	632399	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1456	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38059566	shares
	us-gaap	Net Income Loss NetIncomeLoss	-2959158	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1980990	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.07
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	12156	USD
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	193333	USD
	us-gaap	Interest Expense Other InterestExpenseOther	175247	USD
	us-gaap	Interest Expense Other InterestExpenseOther	599994	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	54924	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-160928	USD
	us-gaap	Profit Loss ProfitLoss	-2959158	USD
	us-gaap	Profit Loss ProfitLoss	-1982446	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27991393	shares
CY2013Q2	us-gaap	Sales Revenue Net SalesRevenueNet	0	USD
CY2012Q2	us-gaap	Sales Revenue Net SalesRevenueNet	0	USD
CY2013Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	165087	USD
CY2012Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	241264	USD
CY2013Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1400515	USD
CY2012Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1052132	USD
CY2013Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	0	USD
CY2012Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	30847	USD
CY2013Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	56976	USD
CY2012Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	49958	USD
CY2013Q2	us-gaap	Costs And Expenses CostsAndExpenses	1622578	USD
CY2012Q2	us-gaap	Costs And Expenses CostsAndExpenses	1374201	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1622578	USD
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1374201	USD
CY2013Q2	xxii	Derivative Gains Losses Net DerivativeGainsLossesNet	1258502	USD
CY2012Q2	xxii	Derivative Gains Losses Net DerivativeGainsLossesNet	1875399	USD
CY2013Q2	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	5610	USD
CY2012Q2	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	55052	USD
CY2013Q2	us-gaap	Interest Expense Other InterestExpenseOther	76269	USD
CY2012Q2	us-gaap	Interest Expense Other InterestExpenseOther	304379	USD
CY2013Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1176623	USD
CY2012Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1515968	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-445955	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	141767	USD
CY2013Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.01
CY2012Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.00
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39794189	shares
CY2012Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29257426	shares
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1936931	USD
	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	93361	USD
	xxii	Stock Issued During Period Warrants Excercised Value StockIssuedDuringPeriodWarrantsExcercisedValue	35067	USD
	xxii	Other Contributed Capital OtherContributedCapital	1660	USD
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	4232	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	13018	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	110063	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	721906	USD
	xxii	Non Cash Interest On Convertible Debt NonCashInterestOnConvertibleDebt	17386	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	745201	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1024451	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	26533	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	116940	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	494785	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	22802	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-141322	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-312858	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	336125	USD
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	6172	USD
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-19673	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-127770	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-104591	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1507064	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1032116	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	14620	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
	us-gaap	Payments To Acquire Furniture And Fixtures PaymentsToAcquireFurnitureAndFixtures	14398	USD
	us-gaap	Payments To Acquire Furniture And Fixtures PaymentsToAcquireFurnitureAndFixtures	0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-29018	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	150000	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	50000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	395286	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	35000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	339250	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	2500	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	6378	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-3893	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-3134	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1987624	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	781988	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	451542	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-250128	USD
CY2011Q4	us-gaap	Cash Cash	252249	USD
CY2012Q2	us-gaap	Cash Cash	2121	USD
	us-gaap	Interest Paid Net InterestPaidNet	32339	USD
	us-gaap	Interest Paid Net InterestPaidNet	11741	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	xxii	Issuance Of Common Stock In Exchange For Account Payable IssuanceOfCommonStockInExchangeForAccountPayable	0	USD
	xxii	Issuance Of Common Stock In Exchange For Account Payable IssuanceOfCommonStockInExchangeForAccountPayable	-359754	USD
	xxii	Conversion Of Accounts Payable To Note Payable ConversionOfAccountsPayableToNotePayable	769377	USD
	xxii	Conversion Of Accounts Payable To Note Payable ConversionOfAccountsPayableToNotePayable	0	USD
	xxii	Conversion Of Accrued Interest To Note Payable ConversionOfAccruedInterestToNotePayable	26422	USD
	xxii	Conversion Of Accrued Interest To Note Payable ConversionOfAccruedInterestToNotePayable	0	USD
	xxii	Common Stock To Be Issued For Services CommonStockToBeIssuedForServices	0	USD
	xxii	Common Stock To Be Issued For Services CommonStockToBeIssuedForServices	171246	USD
	xxii	Conversion Of Notes Payable And Accrued Interest To Common Stock ConversionOfNotesPayableAndAccruedInterestToCommonStock	0	USD
	xxii	Conversion Of Notes Payable And Accrued Interest To Common Stock ConversionOfNotesPayableAndAccruedInterestToCommonStock	120750	USD
	xxii	Dividend Payable On Preferred Stock DividendPayableOnPreferredStock	93361	USD
	xxii	Dividend Payable On Preferred Stock DividendPayableOnPreferredStock	0	USD
	xxii	Refinance Of Note Payable To Accounts Payable RefinanceOfNotePayableToAccountsPayable	57500	USD
	xxii	Refinance Of Note Payable To Accounts Payable RefinanceOfNotePayableToAccountsPayable	0	USD
	xxii	Issuance Of Warrants As Derivative Liability Instrument IssuanceOfWarrantsAsDerivativeLiabilityInstrument	4174044	USD
	xxii	Issuance Of Warrants As Derivative Liability Instrument IssuanceOfWarrantsAsDerivativeLiabilityInstrument	152100	USD
	xxii	Patent And Trademark Additions Included In Accounts Payable PatentAndTrademarkAdditionsIncludedInAccountsPayable	85426	USD
	xxii	Patent And Trademark Additions Included In Accounts Payable PatentAndTrademarkAdditionsIncludedInAccountsPayable	74152	USD
	xxii	Office Furniture And Fixture Additions Included In Accounts Payable OfficeFurnitureAndFixtureAdditionsIncludedInAccountsPayable	8707	USD
	xxii	Office Furniture And Fixture Additions Included In Accounts Payable OfficeFurnitureAndFixtureAdditionsIncludedInAccountsPayable	0	USD
	xxii	Deferred Private Placement Cost Additions Included In Accounts Payable DeferredPrivatePlacementCostAdditionsIncludedInAccountsPayable	0	USD
	xxii	Deferred Private Placement Cost Additions Included In Accounts Payable DeferredPrivatePlacementCostAdditionsIncludedInAccountsPayable	5000	USD
	xxii	Deferred Financing And Other Debt Related Costs DeferredFinancingAndOtherDebtRelatedCosts	0	USD
	xxii	Deferred Financing And Other Debt Related Costs DeferredFinancingAndOtherDebtRelatedCosts	10000	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	2034664	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	0	USD
	xxii	Proceeds Exercise Of Warrants ProceedsExerciseOfWarrants	-542229	USD
	xxii	Proceeds Exercise Of Warrants ProceedsExerciseOfWarrants	0	USD
	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	1660	USD
	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	0	USD
	xxii	Issuance Of Common Stock In Exchange For Deferred Private Placement Payable IssuanceOfCommonStockInExchangeForDeferredPrivatePlacementPayable	0	USD
	xxii	Issuance Of Common Stock In Exchange For Deferred Private Placement Payable IssuanceOfCommonStockInExchangeForDeferredPrivatePlacementPayable	-36875	USD
	xxii	Reclassification Of Derivative Liability To Equity ReclassificationOfDerivativeLiabilityToEquity	204513	USD
	xxii	Reclassification Of Derivative Liability To Equity ReclassificationOfDerivativeLiabilityToEquity	0	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	1427705	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
	xxii	Supplemental Accounts Payable SupplementalAccountsPayable	769377	USD
	xxii	Supplemental Accounts Payable SupplementalAccountsPayable	396629	USD
	xxii	Deferred Private Placement Costs Charged To Contributed Capital DeferredPrivatePlacementCostsChargedToContributedCapital	0	USD
	xxii	Deferred Private Placement Costs Charged To Contributed Capital DeferredPrivatePlacementCostsChargedToContributedCapital	4526	USD
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	USD
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	786500	USD
	xxii	Issuance Of Common Stock Value In Payments Of Financing Cost IssuanceOfCommonStockValueInPaymentsOfFinancingCost	416666	shares
	xxii	Issuance Of Common Stock Value In Payments Of Financing Cost IssuanceOfCommonStockValueInPaymentsOfFinancingCost	0	shares
	us-gaap	Use Of Estimates UseOfEstimates	<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><em>Use of Estimates</em></strong> <strong>-</strong> The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.</div> </div>
	xxii	Fees And Expense Reimbursements Paid FeesAndExpenseReimbursementsPaid	1800000	USD
CY2013Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2326630	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	981550	USD
CY2012Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2226586	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	873282	USD
CY2013Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
CY2012Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	5859	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	225000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	225000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	225000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	225000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	225000	USD
CY2013Q2	xxii	Volume Of Commodity Sold VolumeOfCommoditySold	0	Number
	xxii	Volume Of Commodity Sold VolumeOfCommoditySold	0	Number
CY2012	xxii	Volume Of Commodity Sold VolumeOfCommoditySold	12000000	Number
CY2011	xxii	Volume Of Commodity Sold VolumeOfCommoditySold	12000000	Number
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 36.3pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><em>Reclassifications</em></strong> <em>-</em> Certain items in the 2012 financial statements have been reclassified to conform to the 2013 classification.</div> </div>
CY2013Q2	xxii	Contract Settlement Expected Costs ContractSettlementExpectedCosts	1000000	USD
CY2013Q2	us-gaap	Deferred Set Up Costs Noncurrent DeferredSetUpCostsNoncurrent	40000	USD
CY2012Q4	xxii	Total Carrying Amount Of Convertible Notes TotalCarryingAmountOfConvertibleNotes	1409000	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	2035000	USD
CY2013Q2	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.0999	pure
CY2013Q2	xxii	Percentage Of Common Stock Monetary Damages PercentageOfCommonStockMonetaryDamages	0.02	pure
	xxii	Non Cash Consideration Expense NonCashConsiderationExpense	3987655	USD
	xxii	Increase Decrease In Capital IncreaseDecreaseInCapital	204513	USD
	xxii	Issuance Of Preferred Stock Commission Description IssuanceOfPreferredStockCommissionDescription	ten percent (10%) of the cash received by the Company and (ii) 416,666 shares of common stock. In the event the Purchasers exercise for cash any of the Warrants, then the Company will also pay an additional cash commission to Chardan Capital Markets LLC equal to eight percent (8%) (with no additional equity) of any such additional cash amounts received by us. The Comany owed $47,150 to Chardan Capital Markets, LLC as of June 30, 2013 as a result of the cash exercise of 982,300 Series B Warrants. This amount is included in accrued expenses on the balance sheet. In July 2013, the Company paid $100,000 to Chardan Capital Markets, LLC in full satisfaction of the commission due on the cash exercise of all Series B Warrants. As a result of the Series C Warrant exercise in August 2013, an additional $60,000 commission will be paid to Chardan Capital Markets, LLC. In conjunction with the Series A-1 Preferred Stock private placement, the Company issued 203,167 lock-up warrants to stockholders that participated in previous private placements. These warrants were valued at $168,402 and are considered liabilities due to a down round provision. This amount was also considered a cost of the Series A-1 Preferred Stock private placement. After deducting fees and expenses, the aggregate net proceeds from the sale of the Series A-1 Preferred Shares and the Warrants were $2.035million. The net proceeds were earmarked for the payment of certain financial obligations and for working capital and other general corporate purposes
CY2012Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1710833	shares
CY2012Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1710833	shares
CY2012Q2	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	1026500	USD
CY2012Q2	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	786500	USD
CY2012Q2	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	150000	USD
CY2012Q2	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.04	pure
CY2012Q2	xxii	Non Cash Equity Method Investments NonCashEquityMethodInvestments	90000	USD
CY2012Q2	xxii	Warrants Exercise Price WarrantsExercisePrice	1.00
CY2012Q2	xxii	Issuance Of Warrant Value IssuanceOfWarrantValue	1841000	USD
CY2012Q2	xxii	Non Cash Consideration Expense NonCashConsiderationExpense	814500	USD
CY2012Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	3238000	shares
CY2012Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1619000	shares
CY2012Q4	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	809500	USD
CY2012Q4	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	681000	USD
CY2012Q4	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	98500	USD
CY2012Q4	xxii	Forgiveness Of Directors Fees ForgivenessOfDirectorsFees	30000	USD
CY2012Q4	xxii	Warrants Exercise Price WarrantsExercisePrice	1.00
CY2012Q4	xxii	Issuance Of Warrant Value IssuanceOfWarrantValue	353747	USD
CY2013Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.04	pure
CY2012Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.04	pure
	us-gaap	Debt Instrument Basis Spread On Variable Rate1 DebtInstrumentBasisSpreadOnVariableRate1	0.0075	pure
CY2012	us-gaap	Debt Instrument Basis Spread On Variable Rate1 DebtInstrumentBasisSpreadOnVariableRate1	0.0075	pure
CY2013Q2	xxii	Loan Repayment Terms Minimum LoanRepaymentTermsMinimum	P30D
	us-gaap	Stock Issued During Period Value Issued For Cash StockIssuedDuringPeriodValueIssuedForCash	1000000	USD
CY2013Q2	us-gaap	Notes Payable NotesPayable	1225013	USD
CY2012Q4	us-gaap	Notes Payable NotesPayable	617000	USD
CY2011Q4	us-gaap	Share Price SharePrice	0.90
CY2012Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	328197	USD
CY2012Q4	xxii	Convertible Notes Face Amount ConvertibleNotesFaceAmount	120750	USD
CY2012Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	55000	USD
CY2012	xxii	Conversion Of Convertible Notes Shares Of Common Stock Per Convertible Note ConversionOfConvertibleNotesSharesOfCommonStockPerConvertibleNote	161494	shares
CY2012	xxii	Warrants Issued To Purchase Common Stock WarrantsIssuedToPurchaseCommonStock	193793	shares
CY2012Q4	xxii	Unamortized Discount On Convertible Notes UnamortizedDiscountOnConvertibleNotes	66000	USD
CY2012	xxii	Warrant Liabilities Fair Value WarrantLiabilitiesFairValue	152000	USD
CY2012	us-gaap	Interest Expense Debt InterestExpenseDebt	31000	USD
CY2013Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	1.50
CY2013Q1	xxii	Convertible Notes Face Amount ConvertibleNotesFaceAmount	396750	USD
CY2013Q1	xxii	Warrant Liabilities Fair Value WarrantLiabilitiesFairValue	1445091	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	17386	USD
CY2013Q2	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	24233	USD
CY2013Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	222600	USD
CY2013Q2	xxii	Convertible Debt Fair Value ConvertibleDebtFairValue	222600	USD
CY2012Q4	xxii	Convertible Debt Fair Value ConvertibleDebtFairValue	2028100	USD
CY2013Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	-11545	USD
CY2013Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	198367	USD
CY2012Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	1893804	USD
CY2011	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	22500	USD
CY2013Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	0.60
CY2013Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	0.60
	xxii	Warrant Exercise Price WarrantExercisePrice	0.72
CY2013Q2	xxii	Loss As Result Of Change In Fair Value LossAsResultOfChangeInFairValue	1258502	USD
	xxii	Loss As Result Of Change In Fair Value LossAsResultOfChangeInFairValue	4229982	USD
CY2011Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	550000	USD
CY2012	xxii	Change In Fair Value Of Warrant Liabilities ChangeInFairValueOfWarrantLiabilities	1183543	USD
CY2011Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	8668701	shares
CY2012Q4	xxii	Class Of Warrant Or Right Issued ClassOfWarrantOrRightIssued	3523033	shares
CY2012	xxii	Common Stock Warrants Issued Additional Number CommonStockWarrantsIssuedAdditionalNumber	780930	shares
CY2012	xxii	Number Of Warrants Exercised NumberOfWarrantsExercised	0	shares
	xxii	Common Stock Warrants Issued Additional Number CommonStockWarrantsIssuedAdditionalNumber	896223	shares
CY2013Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	22984827	shares
CY2013Q2	xxii	Class Of Warrant Or Right Issued ClassOfWarrantOrRightIssued	10098240	shares
	xxii	Change In Fair Value Of Warrant Liabilities ChangeInFairValueOfWarrantLiabilities	-4229982	USD
CY2012Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	12972664	shares
CY2013Q2	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	3369	USD
	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	23558	USD
CY2013Q2	us-gaap	Defined Benefit Plan Funded Percentage DefinedBenefitPlanFundedPercentage	0.03	pure
	xxii	Lease Term LeaseTerm	P3Y
	xxii	Agreement Expiration Period AgreementExpirationPeriod	2022
	xxii	Milestone Payment MilestonePayment	150000	USD
CY2013Q2	xxii	Annual License Fee AnnualLicenseFee	75000	USD
CY2012Q2	xxii	Patent Initiative Expenses PatentInitiativeExpenses	13448	USD
CY2013Q2	xxii	Patent Initiative Expenses PatentInitiativeExpenses	9150	USD
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	28000	USD
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	45000	USD
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	10000	USD
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	38059566	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	27991393	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2013Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2012Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2013Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	39794189	shares
CY2012Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	29257426	shares
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2012Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	26019860	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17303887	shares
CY2013Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	168000	USD
CY2013Q2	xxii	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedGrantDateFairValue	51000	USD
CY2013Q2	xxii	Unrecognized Compensation Expense To Be Recognized In Next Twelve Months UnrecognizedCompensationExpenseToBeRecognizedInNextTwelveMonths	68000	USD
CY2013Q2	xxii	Unrecognized Compensation Expense To Be Recognized In Year Two UnrecognizedCompensationExpenseToBeRecognizedInYearTwo	100000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.68
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.60
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	186959	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	242020	USD
	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0189	pure
	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0171	pure
	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Fair Value Assumptions Expected Volatility Rate FairValueAssumptionsExpectedVolatilityRate	0.9	pure
	us-gaap	Fair Value Assumptions Expected Volatility Rate FairValueAssumptionsExpectedVolatilityRate	0.9	pure
	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P10Y
	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P10Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	215000	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	680000	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	680000	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.69
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.80
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.73
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.73
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y1M6D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P9Y1M6D
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	25200	USD
CY2013Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	25200	USD
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	465000	shares

Files In Submission

Name	View Source	Status
0001144204-13-042850-index-headers.html	Edgar Link	pending
0001144204-13-042850-index.html	Edgar Link	pending
0001144204-13-042850.txt	Edgar Link	pending
0001144204-13-042850-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R1.xml	Edgar Link	unprocessable
R10.htm	Edgar Link	pending
R10.xml	Edgar Link	unprocessable
R11.htm	Edgar Link	pending
R11.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R12.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R13.xml	Edgar Link	unprocessable
R14.htm	Edgar Link	pending
R14.xml	Edgar Link	unprocessable
R15.htm	Edgar Link	pending
R15.xml	Edgar Link	unprocessable
R16.htm	Edgar Link	pending
R16.xml	Edgar Link	unprocessable
R17.htm	Edgar Link	pending
R17.xml	Edgar Link	unprocessable
R18.htm	Edgar Link	pending
R18.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R19.xml	Edgar Link	unprocessable
R2.htm	Edgar Link	pending
R2.xml	Edgar Link	unprocessable
R20.htm	Edgar Link	pending
R20.xml	Edgar Link	unprocessable
R21.htm	Edgar Link	pending
R21.xml	Edgar Link	unprocessable
R22.htm	Edgar Link	pending
R22.xml	Edgar Link	unprocessable
R23.htm	Edgar Link	pending
R23.xml	Edgar Link	unprocessable
R24.htm	Edgar Link	pending
R24.xml	Edgar Link	unprocessable
R25.htm	Edgar Link	pending
R25.xml	Edgar Link	unprocessable
R26.htm	Edgar Link	pending
R26.xml	Edgar Link	unprocessable
R27.htm	Edgar Link	pending
R27.xml	Edgar Link	unprocessable
R28.htm	Edgar Link	pending
R28.xml	Edgar Link	unprocessable
R29.htm	Edgar Link	pending
R29.xml	Edgar Link	unprocessable
R3.htm	Edgar Link	pending
R3.xml	Edgar Link	unprocessable
R30.htm	Edgar Link	pending
R30.xml	Edgar Link	unprocessable
R31.htm	Edgar Link	pending
R31.xml	Edgar Link	unprocessable
R32.htm	Edgar Link	pending
R32.xml	Edgar Link	unprocessable
R33.htm	Edgar Link	pending
R33.xml	Edgar Link	unprocessable
R34.htm	Edgar Link	pending
R34.xml	Edgar Link	unprocessable
R35.htm	Edgar Link	pending
R35.xml	Edgar Link	unprocessable
R36.htm	Edgar Link	pending
R36.xml	Edgar Link	unprocessable
R37.htm	Edgar Link	pending
R37.xml	Edgar Link	unprocessable
R38.htm	Edgar Link	pending
R38.xml	Edgar Link	unprocessable
R39.htm	Edgar Link	pending
R39.xml	Edgar Link	unprocessable
R4.htm	Edgar Link	pending
R4.xml	Edgar Link	unprocessable
R40.htm	Edgar Link	pending
R40.xml	Edgar Link	unprocessable
R41.htm	Edgar Link	pending
R41.xml	Edgar Link	unprocessable
R42.htm	Edgar Link	pending
R42.xml	Edgar Link	unprocessable
R43.htm	Edgar Link	pending
R43.xml	Edgar Link	unprocessable
R44.htm	Edgar Link	pending
R44.xml	Edgar Link	unprocessable
R45.htm	Edgar Link	pending
R45.xml	Edgar Link	unprocessable
R46.htm	Edgar Link	pending
R46.xml	Edgar Link	unprocessable
R47.htm	Edgar Link	pending
R47.xml	Edgar Link	unprocessable
R48.htm	Edgar Link	pending
R48.xml	Edgar Link	unprocessable
R49.htm	Edgar Link	pending
R49.xml	Edgar Link	unprocessable
R5.htm	Edgar Link	pending
R5.xml	Edgar Link	unprocessable
R50.htm	Edgar Link	pending
R50.xml	Edgar Link	unprocessable
R51.htm	Edgar Link	pending
R51.xml	Edgar Link	unprocessable
R6.htm	Edgar Link	pending
R6.xml	Edgar Link	unprocessable
R7.htm	Edgar Link	pending
R7.xml	Edgar Link	unprocessable
R8.htm	Edgar Link	pending
R8.xml	Edgar Link	unprocessable
R9.htm	Edgar Link	pending
R9.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v351380_10q.htm	Edgar Link	pending
v351380_ex10-1.htm	Edgar Link	pending
v351380_ex31-1.htm	Edgar Link	pending
v351380_ex31-2.htm	Edgar Link	pending
v351380_ex32-1.htm	Edgar Link	pending
xxii-20130630.xml	Edgar Link	completed
xxii-20130630.xsd	Edgar Link	pending
xxii-20130630_cal.xml	Edgar Link	unprocessable
xxii-20130630_def.xml	Edgar Link	unprocessable
xxii-20130630_lab.xml	Edgar Link	unprocessable
xxii-20130630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XXII
22nd Century Group, Inc. Stock $xxii

2013 Q2 Form 10-Q Financial Statement

#000114420413042850 Filed on August 05, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XXII 22nd Century Group, Inc. Stock $xxii

2013 Q2 Form 10-Q Financial Statement

#000114420413042850 Filed on August 05, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XXII
22nd Century Group, Inc. Stock $xxii